Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Garber

Showing results (371-380 of 605) with videos related to

Pageof 61
Sort By:
The American Journal of Surgical Pathology|May 23, 2012
Pathologic features and immunophenotype of estrogen receptor-positive breast cancers in BRCA1 mutation carriersJennifer S Kaplan, Stuart J Schnitt, Laura C Collins, et al.
American Journal of Human Genetics|January 1, 1995
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage ConsortiumS A Narod, D Ford, P Devilee, et al.
The American Journal of Cardiology|January 15, 1994
Comparison of dobutamine and exercise using technetium-99m sestamibi imaging for the evaluation of coronary artery diseaseS D Herman, K A LaBresh, C D Santos-Ocampo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2013
Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphomaAndrea K Ng, Judy E Garber, Lisa R Diller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2008
Research issues affecting preoperative systemic therapy for operable breast cancerAntonio C Wolff, Donald Berry, Lisa A Carey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2025
The Burden of Antimicrobial Resistant Bacteremia in Ontario: A Population-wide Analysis of Attributable Mortality from 110 Pathogen-Antibiotic CombinationsKevin A Brown, Daniel J Fridman, Gary E Garber, et al.
Breast Cancer Research and Treatment|April 13, 2013
Prevalence of germline TP53 mutations in HER2+ breast cancer patientsMichelle G Rath, Serena Masciari, Rebecca Gelman, et al.
The Journal of Cell Biology|May 12, 2020
E3 ligase RFWD3 is a novel modulator of stalled fork stability in BRCA2-deficient cellsHaohui Duan, Sarah Mansour, Rachel Reed, et al.
Oncogene|August 26, 1998
Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancerM G FitzGerald, D J Marsh, D Wahrer, et al.
Cancer Genetics|February 27, 2022
Vulvar Melanoma in association with germline MITF p.E318K variantDiane R Koeller, Alison Schwartz, Mia S DeSimone, et al.
Pageof 61

Showing results (371-380 of 605) with videos related to

Sort By:
Pageof 61
The American Journal of Surgical Pathology|May 23, 2012
Pathologic features and immunophenotype of estrogen receptor-positive breast cancers in BRCA1 mutation carriersJennifer S Kaplan, Stuart J Schnitt, Laura C Collins, et al.
American Journal of Human Genetics|January 1, 1995
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage ConsortiumS A Narod, D Ford, P Devilee, et al.
The American Journal of Cardiology|January 15, 1994
Comparison of dobutamine and exercise using technetium-99m sestamibi imaging for the evaluation of coronary artery diseaseS D Herman, K A LaBresh, C D Santos-Ocampo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2013
Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphomaAndrea K Ng, Judy E Garber, Lisa R Diller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2008
Research issues affecting preoperative systemic therapy for operable breast cancerAntonio C Wolff, Donald Berry, Lisa A Carey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2025
The Burden of Antimicrobial Resistant Bacteremia in Ontario: A Population-wide Analysis of Attributable Mortality from 110 Pathogen-Antibiotic CombinationsKevin A Brown, Daniel J Fridman, Gary E Garber, et al.
Breast Cancer Research and Treatment|April 13, 2013
Prevalence of germline TP53 mutations in HER2+ breast cancer patientsMichelle G Rath, Serena Masciari, Rebecca Gelman, et al.
The Journal of Cell Biology|May 12, 2020
E3 ligase RFWD3 is a novel modulator of stalled fork stability in BRCA2-deficient cellsHaohui Duan, Sarah Mansour, Rachel Reed, et al.
Oncogene|August 26, 1998
Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancerM G FitzGerald, D J Marsh, D Wahrer, et al.
Cancer Genetics|February 27, 2022
Vulvar Melanoma in association with germline MITF p.E318K variantDiane R Koeller, Alison Schwartz, Mia S DeSimone, et al.
Pageof 61